Try the new portal at hg19 or hg38.

• Figure 2: Visualizing common or rare regulatory variants in T-ALL samples on Cohort View.
• Figure 3: Sample View of interchromsomal rearrangement leading to MYC dysregulation by enhancer hijacking.
• Figure 4: Assessing aberrant splicing in CREBBP caused by somatic splice site variants.
• Figure 5: MYC dysregulation by enhancer duplications in pediatric cancers.
• Figure 7: Visualizing intratumor heterogeneity of TCGA GBM at EGFR locus.
• Online example 1: TP53 bi-allelic loss in adrenocortical tumors.
• Online example 2: IKZF1 haploinsufficiency in B-ALL.
• Online example 3: MYB alteration status in T-ALL and the association with patient outcome.
• Online example 4: Association of MDM2 expression in AML with patient outcome.
• Online example 5: Matrix View of mutual-exclusive or co-mutation patterns and association with patient outcome.
• Online example 6: A TP53 splice site mutation causing intron retention inspected via Sample View.
• Online example 7: APOBEC signature is associated with kataegis as revealed by rainfall plot in Sample View.
• Online example 8: TCGA DLBC cohort mutation profile over CDKN2A/B locus.
• Online example 9: TCGA SKCM cohort mutation profile over TERT.
• Supplementary figure 2: Diverse alterations in B-ALL targeting CREBBP RING domain.
• Supplementary figure 3: CNV and chromatin interactions over MYC and its enhancers.
• Supplementary figure 4: DUX4 but not NOTCH1 likely binds at N-ME in NALM6.
• Supplementary figure 5: In EGFR-amplified GBM, clonality of oncogenic coding mutations can vary with the presence or absence of the vIII isoform.
• Supplementary figure 6: Illustrating the EGFR exon 8 ITD event along with the reinterpretation of a sequence mutation.